GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2526 - 2550 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▲
IgA Patient 3 11 mild
G92823JK
355
IgA Patient 1 10 moderate
G62826CL
356
IgA Patient 2 24 mild
G48898TH
356
IgA Patient 2 3 mild
G18057VI
356
IgA Patient 2 3 mild
G36374CE
356
IgA Patient 2 3 mild
G62826CL
356
IgM Patient 2 24 mild
G90223GH
356
IgM Patient 2 3 mild
G09482NW
356
IgA Patient 3 -180 mild
G77974XY
356
IgA Patient 4 12 mild
G90223GH
356
IgA Patient 1 6 moderate
G93351GM
357
IgA Patient 2 15 mild
G68703KI
357
IgA Patient 2 24 mild
G96865DJ
357
IgM Patient 4 12 mild
G84224TW
357
IgA Patient 1 10 moderate
G84224TW
358
IgA Patient 1 6 moderate
G92823JK
358
IgA Patient 2 15 mild
G21460SG
358
IgA Patient 2 24 mild
G82348BZ
358
IgA Patient 4 12 mild
G82204SH
358
IgG Patient 4 12 mild
G68461PT
358
IgA Patient 1 22 moderate
G52880ZN
359
IgA Patient 1 6 moderate
G40696TO
359
IgA Patient 1 6 moderate
G41200QS
359
IgA Patient 4 12 mild
G07483YN
359
IgA Patient 4 12 mild
G31265MS
359

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024